Cooperative translational control of gene expression by Ras and Akt in cancer

被引:47
作者
Parsa, AT
Holland, EC
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg Neurosurg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Canc Biol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Genet, New York, NY 10021 USA
[5] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.molmed.2004.10.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ras and Akt are signaling proteins that mediate fundamental aspects of normal growth and development in many organisms. When the Ras and Akt pathways become overly active, malignant transformation of normal tissue can occur. The combined activity of these two proteins has generated the transformation of human cell cultures and tumor formation in mice. In this review we highlight malignant glioma as a tumor type in which Ras and Akt pathways cooperate to cause tumorigenesis and regulate translation. The downstream components of these pathways have provided therapeutic targets that are currently being tested in clinical trials.
引用
收藏
页码:607 / 613
页数:7
相关论文
共 53 条
[1]  
ANTONETTI DA, 1993, J BIOL CHEM, V268, P25277
[2]  
Avruch J, 2001, Prog Mol Subcell Biol, V26, P115
[3]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .10. THE RAS GENE FAMILY AND HUMAN CARCINOGENESIS [J].
BOS, JL .
MUTATION RESEARCH, 1988, 195 (03) :255-271
[4]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[5]   Targets and mechanisms for the regulation of translation in malignant transformation [J].
Clemens, MJ .
ONCOGENE, 2004, 23 (18) :3180-3188
[6]   Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome [J].
Corradetti, MN ;
Inoki, K ;
Bardeesy, N ;
DePinho, RA ;
Guan, KL .
GENES & DEVELOPMENT, 2004, 18 (13) :1533-1538
[7]   Clinical development of mammalian target of rapamycin inhibitors [J].
Dancey, JE .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (05) :1101-+
[8]  
de Moor CH, 2001, INT REV CYTOL, V203, P567
[9]   B7-H1 pathway and its role in the evasion of tumor immunity [J].
Dong, HD ;
Chen, LP .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (05) :281-287
[10]  
Dong HD, 1999, NAT MED, V5, P1365